{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:02:58Z","timestamp":1792677778560,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Available epidemiological data on primary biliary cholangitis (PBC) in Sweden originate from regional studies in the 1980s and may not reflect modern day PBC. We aimed to estimate incidence and prevalence, survival and death causes, and gender differences in PBC. We used international classification of disease (ICD) codes to identify patients with PBC in inpatient and outpatient registries 1987\u20132014 who were then linked to the Swedish cause of death, cancer and prescribed drug registries. Each PBC patient was matched with 10 reference individuals from the general population. In sensitivity analyses, we examined PBC patients identified through clinical patient records from Karolinska, Sahlgrenska and \u00d6rebro University Hospitals. We identified 5,350 adults with PBC. Prevalence of PBC increased steadily from 5.0 (1987) to 34.6 (2014) per 100,000 inhabitants whereas the yearly incidence rate was relatively constant with a median of 2.6 per 100,000 person-years, with a female:male gender ratio of 4:1. Compared to reference individuals, PBC individuals aged 15\u201339 years at diagnosis had a substantially higher risk of death (Hazard Ratio [HR] 12.7, 95% Confidence Interval [CI] 8.3\u201319.5) than those diagnosed between 40\u201359 (HR 4.1, 95% CI 3.7\u20134.5) and &gt;60 (HR 3.7, 95% CI 3.5\u20133.9) years of age. Relative risks of mortality were highest in men.\n                    <jats:italic>In conclusion<\/jats:italic>\n                    , we found that recorded prevalence of PBC in Sweden has increased substantially during the last 30 years although incidence has been stable. Patients diagnosed in young adulthood were at a 12.7-fold increased risk of death, and male PBC patients had worse prognosis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-47890-2","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:20:54Z","timestamp":1565245254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-3085","authenticated-orcid":false,"given":"Hanns-Ulrich","family":"Marschall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"S\u00f6derdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thuresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"47890_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey, E. J., Ali, A. H. & Lindor, K. D. Primary biliary cirrhosis. Lancet 386, 1565\u20131575, https:\/\/doi.org\/10.1016\/S0140-6736(15)00154-3 (2015).","journal-title":"Lancet"},{"key":"47890_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jhep.2015.06.031","volume":"63","author":"U Beuers","year":"2015","unstructured":"Beuers, U. et al. Changing nomenclature for PBC: From \u2018cirrhosis\u2019 to \u2018cholangitis\u2019. J. Hepatol. 63, 1285\u20131287, https:\/\/doi.org\/10.1016\/j.jhep.2015.06.031 (2015).","journal-title":"J. Hepatol."},{"key":"47890_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"EAFTSOT Liver","year":"2017","unstructured":"Liver, E. A. F. T. S. O. T. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol. 67, 145\u2013172, https:\/\/doi.org\/10.1016\/j.jhep.2017.03.022 (2017).","journal-title":"J. Hepatol."},{"key":"47890_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrgastro.2015.12","volume":"12","author":"JK Dyson","year":"2015","unstructured":"Dyson, J. K. et al. Novel therapeutic targets in primary biliary cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 12, 147\u2013158, https:\/\/doi.org\/10.1038\/nrgastro.2015.12 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"47890_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares, A., Caballeria, L. & Rodes, J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130, 715\u2013720, https:\/\/doi.org\/10.1053\/j.gastro.2005.12.029 (2006).","journal-title":"Gastroenterology"},{"key":"47890_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot, C. et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48, 871\u2013877, https:\/\/doi.org\/10.1002\/hep.22428 (2008).","journal-title":"Hepatology"},{"key":"47890_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper, E. M. et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136, 1281\u20131287, https:\/\/doi.org\/10.1053\/j.gastro.2009.01.003 (2009).","journal-title":"Gastroenterology"},{"key":"47890_CR8","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi, T. et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am. J. Gastroenterol. 105, 2186\u20132194, https:\/\/doi.org\/10.1038\/ajg.2010.216 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"47890_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot, C., Chazouilleres, O. & Poupon, R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J. Hepatol. 55, 1361\u20131367, https:\/\/doi.org\/10.1016\/j.jhep.2011.02.031 (2011).","journal-title":"J. Hepatol."},{"key":"47890_CR10","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers, W. J. et al. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy. Gastroenterology 149, 1804\u20131812 e1804, https:\/\/doi.org\/10.1053\/j.gastro.2015.07.061 (2015).","journal-title":"Gastroenterology"},{"key":"47890_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone, M. et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology 63, 930\u2013950, https:\/\/doi.org\/10.1002\/hep.28017 (2016).","journal-title":"Hepatology"},{"issue":"9","key":"47890_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"3","author":"Marco Carbone","year":"2018","unstructured":"Carbone, M. et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol, https:\/\/doi.org\/10.1016\/S2468-1253(18)30163-8 (2018).","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"47890_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens, F. et al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N. Engl. J. Med. 375, 631\u2013643, https:\/\/doi.org\/10.1056\/NEJMoa1509840 (2016).","journal-title":"N. Engl. J. Med."},{"key":"47890_CR14","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","volume":"378","author":"C Corpechot","year":"2018","unstructured":"Corpechot, C. et al. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N. Engl. J. Med. 378, 2171\u20132181, https:\/\/doi.org\/10.1056\/NEJMoa1714519 (2018).","journal-title":"N. Engl. J. Med."},{"key":"47890_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/00365521.1984.12005842","volume":"19","author":"S Eriksson","year":"1984","unstructured":"Eriksson, S. & Lindgren, S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand. J. Gastroenterol. 19, 971\u2013976 (1984).","journal-title":"Scand. J. Gastroenterol."},{"key":"47890_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3109\/00365528509089711","volume":"20","author":"J Lofgren","year":"1985","unstructured":"Lofgren, J., Jarnerot, G., Danielsson, D. & Hemdal, I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand. J. Gastroenterol. 20, 647\u2013650 (1985).","journal-title":"Scand. J. Gastroenterol."},{"key":"47890_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/hep.1840110317","volume":"11","author":"A Danielsson","year":"1990","unstructured":"Danielsson, A., Boqvist, L. & Uddenfeldt, P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 11, 458\u2013464 (1990).","journal-title":"Hepatology"},{"key":"47890_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson, J. F. et al. Registers of the Swedish total population and their use in medical research. Eur. J. Epidemiol. 31, 125\u2013136, https:\/\/doi.org\/10.1007\/s10654-016-0117-y (2016).","journal-title":"Eur. J. Epidemiol."},{"key":"47890_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra, K., Beuers, U. & Ponsioen, C. Y. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J. Hepatol. 56, 1181\u20131188, https:\/\/doi.org\/10.1016\/j.jhep.2011.10.025 (2012).","journal-title":"J. Hepatol."},{"key":"47890_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","volume":"24","author":"TR Baldursdottir","year":"2012","unstructured":"Baldursdottir, T. R. et al. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. Eur. J. Gastroenterol. Hepatol. 24, 824\u2013830, https:\/\/doi.org\/10.1097\/MEG.0b013e328353753d (2012).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"47890_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo, A. et al. Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis. Sci. Rep. 6, 25906, https:\/\/doi.org\/10.1038\/srep25906 (2016).","journal-title":"Sci. Rep."},{"key":"47890_CR22","doi-asserted-by":"publisher","unstructured":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 51, 237\u2013267, S0168-8278(09)00309-2 [pii], https:\/\/doi.org\/10.1016\/j.jhep.2009.04.009 (2009).","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"47890_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1586\/egh.13.5","volume":"7","author":"U Volta","year":"2013","unstructured":"Volta, U., Caio, G., Tovoli, F. & De Giorgio, R. Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosis. Expert Rev. Gastroenterol. Hepatol. 7, 253\u2013261, https:\/\/doi.org\/10.1586\/egh.13.5 (2013).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"47890_CR24","doi-asserted-by":"publisher","first-page":"560-569.e7","DOI":"10.1053\/j.gastro.2012.12.005","volume":"144","author":"Marco Carbone","year":"2013","unstructured":"Carbone, M. et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 144, 560\u2013569 e567; quiz e513-564, https:\/\/doi.org\/10.1053\/j.gastro.2012.12.005 (2013).","journal-title":"Gastroenterology"},{"key":"47890_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/hep.1840200116","volume":"20","author":"L Loof","year":"1994","unstructured":"Loof, L. et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 20, 101\u2013104 (1994).","journal-title":"Hepatology"},{"key":"47890_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/hep.25788","volume":"56","author":"Y Liang","year":"2012","unstructured":"Liang, Y., Yang, Z. & Zhong, R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology 56, 1409\u20131417, https:\/\/doi.org\/10.1002\/hep.25788 (2012).","journal-title":"Hepatology"},{"issue":"9","key":"47890_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S2468-1253(18)30177-8","volume":"3","author":"Hanns-Ulrich Marschall","year":"2018","unstructured":"Marschall, H. U. Ensuring timely treatment of patients with primary biliary cholangitis. Lancet Gastroenterol Hepatol, https:\/\/doi.org\/10.1016\/S2468-1253(18)30177-8 (2018).","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"47890_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson, J. F., Otterblad-Olausson, P., Pettersson, B. U. & Ekbom, A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur. J. Epidemiol. 24, 659\u2013667, https:\/\/doi.org\/10.1007\/s10654-009-9350-y (2009).","journal-title":"Eur. J. Epidemiol."},{"key":"47890_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson, J. F. et al. External review and validation of the Swedish national inpatient register. BMC Public Health 11, 450, https:\/\/doi.org\/10.1186\/1471-2458-11-450 (2011).","journal-title":"BMC Public Health"},{"key":"47890_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1411430","volume":"372","author":"A Anell","year":"2015","unstructured":"Anell, A. The public-private pendulum\u2013patient choice and equity in Sweden. N. Engl. J. Med. 372, 1\u20134, https:\/\/doi.org\/10.1056\/NEJMp1411430 (2015).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47890-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:20:19Z","timestamp":1671261619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47890-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47890"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47890-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.U.M. received a grant (for this study) by Intercept, and consultant fees and material support, by Albireo and Intercept. All other authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11525"}}